Curcumin Therapy in Inflammatory Bowel Disease: A Pilot Study

Abstract

Curcumin, a natural compound used as a food additive, has been shown to have anti-inflammatory and antioxidant properties in cell culture and animal studies. A pure curcumin preparation was administered in an open label study to five patients with ulcerative proctitis and five with Crohn's disease. All proctitis patients improved, with reductions in concomitant medications in four, and four of five Crohn's disease patients had lowered CDAI scores and sedimentation rates. This encouraging pilot study suggests the need for double-blind placebo-controlled follow-up studies.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Ammon HPT, Wahl M: Pharmacology of Curcuma longa. Planta Med 57:1–7, 1991

    PubMed  Google Scholar 

  2. 2.

    Satoskar RR, Shah SJ, Shenoy SG: Evaluation of anti-inflammatory property of curcumin (diferuloytmethane) in patients with postoperative inflammation. Int J Pharmacol Ther Toxicol 24:651–654, 1986

    Google Scholar 

  3. 3.

    Surh YJ: Anti-tumor promoting potential of selected spice ingredients with antioxidative and anti-inflammatory activities: a short review. Food Chem Toxicol 40:1091–1097, 2002

    Article  PubMed  Google Scholar 

  4. 4.

    Toda S, Miyase T, Aricht H, Tanizawa H, Takino Y: Natural antioxidant HI antioxidative components isolated from rhizome of curcuma longa. Chem Pharm Bull 33:1725–1728, 1985

    PubMed  Google Scholar 

  5. 5.

    Hanif R, Qiao L, Shiff SJ, Rigas B: Curcumin a natural plant phenolic food additive inhibits cell proliferation and induces ceil cycle changes in colon adenocarcinoma cell lines by prostaglandin-independent pathways. J Lab Clin Med 130:576–584, 1997

    Article  PubMed  Google Scholar 

  6. 6.

    Plummer SM, Holloway KA, Manson MM, Munks RJ, Kaptein A, Farrow S, Howells L: Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-κB activation via the NIK/IKK signaling complex. Oncogene 18:6013–6020, 1999

    Article  PubMed  Google Scholar 

  7. 7.

    Ranjan D, Chen C, Johnston TO, Reddy KS, Khan TT, Nagabhushan M: Curcumin inhibits mitogen stimulated lymphocyte proliferation NF-κB activation and IL-2 signaling. J Surg Res 114:272, 2003

    Article  Google Scholar 

  8. 8.

    Duvoix A, Morceau F, Deihalle S, Schmitz M, Schnekenburger M, Galteau MM, Dicato M, Diederichet M: Induction of apoptosis by curcumin: mediation by giutathione S transferase P1-1 inhibition. Biochem Pharmacol 66:1475–1483, 2003

    Article  PubMed  Google Scholar 

  9. 9.

    Salh B, Assi K, Templeman V, Parhar K, Owen D, Gomez-Munoz A, Jacobsen K: Curcumin attenuates DNB-induced murine colitis. Am J Physiol Gastrointest Liver Physiol 285:G235, 2003

    PubMed  Google Scholar 

  10. 10.

    Sugimoto K, Hanai H, Tozawa K, Aoshi T, Uchijima M, Nagata T, Koide Y: Curcumin prevents and ameliorates trinitrobenzene surfonic acide induced colitis in mice. Gastroenterology 123:1912–1922, 2002

    Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Peter R. Holt MD.

Additional information

Kindly provided by R. Kane Products, Pennsauken, New Jersey.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Holt, P.R., Katz, S. & Kirshoff, R. Curcumin Therapy in Inflammatory Bowel Disease: A Pilot Study. Dig Dis Sci 50, 2191–2193 (2005). https://doi.org/10.1007/s10620-005-3032-8

Download citation

Key Words

  • curcumin
  • ulcerative proctitis
  • Crohn's disease
  • inflammatory bowel disease